本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Axsome Therapeutics, Inc.

184.08
-2.1294-1.14%
成交量:6.64萬
成交額:1,222.94萬
市值:92.80億
市盈率:-39.48
高:186.97
開:186.97
低:182.75
收:186.21
52周最高:191.50
52周最低:86.99
股本:5,041.26萬
流通股本:4,187.28萬
量比:0.26
換手率:0.16%
股息:- -
股息率:- -
每股收益(TTM):-4.6630
每股收益(LYR):-5.9944
淨資產收益率:-275.50%
總資產收益率:-19.79%
市淨率:125.87
市盈率(LYR):-30.71

資料載入中...

2026/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/12

重要事件披露

Form 8-K - Current report
2026/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/31

重要事件披露

Form 8-K - Current report
2025/12/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/03

重要事件披露

Form 8-K - Current report
2025/10/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities